Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "foot"

616 News Found

Salve Group launches Parasoft foot cream to address dry and cracked feet
News | April 17, 2026

Salve Group launches Parasoft foot cream to address dry and cracked feet

This combination works to break down rough patches, improve moisture retention, and enhance overall skin texture


NantBioRenewables expands US manufacturing footprint in Alabama
Biotech | April 15, 2026

NantBioRenewables expands US manufacturing footprint in Alabama

To boost compostable packaging, resin innovation, and supply chain speed


ten23 health expands APAC footprint with new Tokyo office, appoints Noriko Utsumi
Biotech | April 15, 2026

ten23 health expands APAC footprint with new Tokyo office, appoints Noriko Utsumi

Strategic expansion strengthens CDMO’s support for biotech and pharma innovators across the Asia-Pacific region


Happiest Health expands dental care footprint with its second Happiest Pearls Clinic
Healthcare | April 14, 2026

Happiest Health expands dental care footprint with its second Happiest Pearls Clinic

Spread across nearly 4,500 sq. ft., the new clinic combines advanced dental technology, experienced specialists, and an Atithi-first care model


Zuellig Pharma expands Cialis footprint across Asia
News | March 16, 2026

Zuellig Pharma expands Cialis footprint across Asia

The expanded ownership is expected to improve access to Cialis for millions of men in Asia affected by ED and BPH


Entero Healthcare expands MedTech footprint with acquisition of Anand Chemiceutics
Supply Chain | February 10, 2026

Entero Healthcare expands MedTech footprint with acquisition of Anand Chemiceutics

Anand Chemiceutics serves over 1,500 laboratories, hospitals, and government institutions


Siegfried expands US footprint with major acquisition of Noramco & Extractas Bioscience
News | January 30, 2026

Siegfried expands US footprint with major acquisition of Noramco & Extractas Bioscience

The deal brings three high-quality small-molecule drug substance sites into Siegfried’s portfolio


Siegfried expands US footprint with major acquisition of Noramco & Extractas Bioscience
News | January 29, 2026

Siegfried expands US footprint with major acquisition of Noramco & Extractas Bioscience

Siegfried plans to grow its exclusive synthesis business in the US by optimizing controlled substance capacity at the Wilmington and nearby Pennsville sites


Agno Pharma acquires Actylis Eugene, expanding US API manufacturing footprint
News | January 17, 2026

Agno Pharma acquires Actylis Eugene, expanding US API manufacturing footprint

The Eugene facility, with more than 20 years of history, houses a 16,000-square-foot R&D lab and a newly constructed 30,000-square-foot manufacturing facility


NAMSA expands US footprint with Labcorp medical device testing acquisition
News | January 12, 2026

NAMSA expands US footprint with Labcorp medical device testing acquisition

The deal brings Labcorp’s U.S. portfolio—including biocompatibility, microbiological, and analytical testing, as well as preclinical research—under NAMSA’s roof